Increasing use of
chloroquine for treatment of various diseases to drive growth of global
According to TechSci Research report, “Global Chloroquine Market By Type (Injectables, Capsules, Tablets), By Route of Administration (Oral v/s Intravenous), By Dosage (5mg, 500mg, 1000mg), By Application (Arthrophlogosis, Malaria, COVID-19, Others), By Region, Forecast & Opportunities, 2030”, the global chloroquine market is expected to grow at a formidable rate during the forecast period on account of the growing use of the drug in treating various diseases especially as a treatment option to treat the novel coronavirus disease. Though, it has not been proven clinically that the drug can be used to treat coronavirus, but it has been identified that the drug is helpful in improving the early symptoms of the disease especially the respiratory problems. Additionally, the drug is generic, hence potentially affordable and scalable for the treatment of various diseases. However, associated side effects of the drug such as headache, loss of appetite, diarrhea, hair loss, mood swings, among others are expected to hamper the growth of the market during the forecast period.
Browse XX market data Tables and XX Figures spread throughXXX Pages and an in-depth TOC on“Global Chloroquine Market”
The global chloroquine market is segmented based on type, route of administration,
dosage, application and region. Based on type, the market can be categorized
into injectables, capsules and tablets. The tablets segment is expected to
dominate the market during forecast period since tablets are easily available
at affordable prices, durable and have a longer shelf life and are also chewable.
Additionally, tablets can accommodate high doses of active ingredients. Moreover,
the tablets can be split or broken down and then consumed. Furthermore, these
are available in various variable deliverable forms such as quick release,
delayed release, among others. Based on route of administration, the market can
be bifurcated into oral and intravenous. The oral segment is expected to
dominate the market since the drug is generally consumed orally in the form of
tablets or capsules. Based on application, the market can be categorized into arthrophlogosis, rheumatoid arthritis,
malaria, COVID-19 and others. The COVID-19 segment is expected to register the
highest growth during forecast period since it has been identified that the
drug can be used to treat the disease, though not proven clinically.
Additionally, studies suggest that it is helpful in treating some symptoms of
the disease and is being used widely in the treatment guidelines of COVID-19.
Countries such as China, South Korea and Belgium have added chloroquine in
their coronavirus disease treatment guidelines. Also, studies suggest that the
drug has been helpful in treating few cases of the disease in France. Clinical trials
are going on rigorously, but nothing has been proven clinically or approved by
ARTECEF B.V., Fishman Chemical,
LLC, Uniprix Inc., Bayer AG, Abcam Inc., Recipharm, Teva Pharmaceuticals, Mylan
NV, Abbott, Novartis AG and others are some of the leading
players operating in global chloroquine market. The companies operating in the
market are using organic strategies such as product launches, mergers and
collaborations to boost their share. Recently, Mylan NV restarted the production
of chloroquine after the news of its use as a potential treatment for novel
coronavirus disease. Additionally, companies such as Bayer AG and Teva
Pharmaceuticals have donated around 3 million chloroquine tablets to the U.S.
for using it in the treatment of COVID-19.
Customers can also
request for 10% free customization on this report.
“Asia Pacific is expected to
register significant growth in the chloroquine market during the forecast
period, owing to the use of drug for treating various diseases in the region.
Additionally, the drug is being used in the coronavirus treatment guidelines in
various countries such as China and South Korea in the region. If it gets
proven clinically that the drug can be used for the treatment of COVID-19, then
this is expected to create lucrative opportunities for the market players over
the next few years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Global Chloroquine Market By Type (Injectables,
Capsules, Tablets), By Route of Administration (Oral v/s Intravenous), By
Dosage (5mg, 500mg, 1000mg), By Application (Arthrophlogosis, Malaria, COVID-19,
Others), By Region, Forecast & Opportunities, 2030” has evaluated the future growth potential of global chloroquine
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global chloroquine market.